3. Discussion
T2DM, cardiovascular disease, diabetes
CARDIOVASCULAR DISEASE, GASTRIC RETENTION, DISEASE, HAND SWELLING, DIABETES
We will evaluate the real-world efficacy and safety of SR pregabalin and compare medication adherence among T2DM patients with painful DPN. The SR pregabalin formulation has been developed using a floating and swelling gastro-retentive drug delivery system to prolong the gastric retention of pregabalin, and it can be administered once a day.People with chronic conditions, such as cardiovascular disease and diabetes, are frequently confronted with the need to regularly take a substantial number of medications over extended periods of time owing to their underlying disease and other comorbidities.